kabutan

SAPPORO CLINICAL LAB, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5%, Oct-Dec Ordinary Profit Decreases by 9%

Fri Feb 6, 2026 3:30 pm JST Earnings

9776 SAPPORO CLINICAL LABORATORY INC. 【J-GAAP】

Earnings Report

SAPPORO CLINICAL LABORATORY INC. <9776> [TSE Std] announced its financial results after the market closed on February 6th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) increased 4.9% from the same period last year, reaching 580 million yen. Progress toward the full-year plan of 771 million yen was 75.2%, almost the same as the five-year average of 75.6%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to grow 24.0% from the same period last year, reaching 191 million yen.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit decreased to 191 million yen, a 9.0% decrease compared to the same period last year. The operating profit margin worsened from 3.9% in the same period last year to 3.4%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 14,852 414 417 311 93.7 81.1 Feb 9, 2024 J-GAAP
Apr - Dec, 2024 15,275 541 553 367 117.2 78.2 Feb 12, 2025 J-GAAP
Apr - Dec, 2025 15,534 559 580 289 92.9 75.2 Feb 6, 2026 J-GAAP
YoY +1.7% +3.3% +4.9% -21.3% -20.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 10,135 369 364 242 77.4 23 May 12, 2025 J-GAAP
Oct - Mar, 2025 Guidance 10,450 396 382 255 81.7 23 Nov 7, 2025 J-GAAP
YoY +3.1% +7.3% +4.9% +5.4% +5.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 19,682 534 514 380 114.1 23 May 13, 2024 J-GAAP
Mar, 2025 20,131 706 707 464 148.4 23 May 12, 2025 J-GAAP
Mar, 2026 Guidance 20,688 775 771 505 161.9 23 May 12, 2025 J-GAAP
YoY +2.8% +9.8% +9.1% +8.8% +9.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 5,279 204 210 145 46.3 3.9 Feb 12, 2025 J-GAAP
Jan - Mar, 2025 4,856 165 154 97 31.0 3.4 May 12, 2025 J-GAAP
Apr - Jun, 2025 5,066 87 93 47 15.3 1.7 Aug 4, 2025 J-GAAP
Jul - Sep, 2025 5,172 292 296 203 65.3 5.6 Nov 7, 2025 J-GAAP
Oct - Dec, 2025 5,296 180 191 39 12.5 3.4 Feb 6, 2026 J-GAAP
YoY +0.3% -11.8% -9.0% -73.1% -72.9%

Related Articles